A Guide to the Clinical Care of Women with HIVJean R. Anderson DIANE Publishing Inc., 2005 - 612 pages NOTE: NO FURTHER DISCOUNT FOR THIS PRODUCT ITEM -OVERSRTOCK SALE-- Significantly reduced price. Edited by Jean R. Anderson. This guide addresses the health care needs unique to women with HIV. It targets clinicians who provide primary care to women as well as those seeking an understanding of how to take care of women with HIV/AIDS. This guide includes tables, figures, color plates, resources, references, and indices. This 2005 edition includes new chapters on international issues and nutrition. Edge indexed." |
From inside the book
Results 1-5 of 48
Page 98
... monitor the course and treatment of HIV infection ( see below ) . The three most common techniques are reverse transcriptase polymerase chain reaction ( RT - PCR ) , a branched DNA ( bDNA ) technique , and nucleic acid sequence - based ...
... monitor the course and treatment of HIV infection ( see below ) . The three most common techniques are reverse transcriptase polymerase chain reaction ( RT - PCR ) , a branched DNA ( bDNA ) technique , and nucleic acid sequence - based ...
Page 106
... monitor possible medication toxicities , complications of HIV , and other possible illnesses . The CD4 count and viral load allow assessment of disease progression and effects of antiretroviral therapy . In following the CD4 count over ...
... monitor possible medication toxicities , complications of HIV , and other possible illnesses . The CD4 count and viral load allow assessment of disease progression and effects of antiretroviral therapy . In following the CD4 count over ...
Page 149
... Monitor Response Full response will generally not be seen for at least 4 wk At 4 wk , if Hgb increases > 1g / dL , continue at this dose . At 4 wk , if Hgb increases < 1g / dL , increase dose to 60,000 units / wk Correct underlying ...
... Monitor Response Full response will generally not be seen for at least 4 wk At 4 wk , if Hgb increases > 1g / dL , continue at this dose . At 4 wk , if Hgb increases < 1g / dL , increase dose to 60,000 units / wk Correct underlying ...
Page 200
... monitor liver function ; sig- nificant drug interactions with some antiretrovirals ( see Chapter XIV on Pharmacologic Considerations in HIV- infected Pregnant Patients ) 6. immune reconstitution ; potential benefit with protease ...
... monitor liver function ; sig- nificant drug interactions with some antiretrovirals ( see Chapter XIV on Pharmacologic Considerations in HIV- infected Pregnant Patients ) 6. immune reconstitution ; potential benefit with protease ...
Page 267
... monitor changes with ARV therapy ; at milestones for therapeutic decisions , re : ARV therapy / Ol prophylaxis Acute HIV infection , virologic failure , sub - optimal viral suppression after initiation of ARV therapy , or high ...
... monitor changes with ARV therapy ; at milestones for therapeutic decisions , re : ARV therapy / Ol prophylaxis Acute HIV infection , virologic failure , sub - optimal viral suppression after initiation of ARV therapy , or high ...
Other editions - View all
Common terms and phrases
abacavir abnormal adherence adolescents AIDS alcohol Amprenavir antiretroviral drugs antiretroviral therapy assessment associated AUC increased behavior candidiasis CD4 cell counts CD4 count chronic Clin condom contraception counseling culture decreased Delavirdine diagnosis didanosine dose Efavirenz evaluation exposure fetal HAART hepatic hepatic metabolism HIV and Reproduction HIV disease HIV infection HIV RNA HIV transmission HIV-Infected Pregnant Patients HIV-infected women HIV-positive women HIV/AIDS human immunodeficiency virus Immediate Major Immediate Moderate increased risk Indinavir Induction of hepatic infants Inhibition of hepatic interaction intervention lamivudine lesions maternal mg bid mg qd Monitor Nelfinavir nevirapine Nutrition oral pain Pap smear perinatal transmission Pharmacologic Considerations potential pregnancy pregnant women Primary Medical prophylaxis providers psychiatric recommended regimen resistance rifabutin ritonavir Saquinavir stavudine studies substance abuse symptoms Table tenofovir teratogenic toxicity treatment vaccine vaginal viral load women with HIV zidovudine
References to this book
The Experiences of Women with AIDS Who Have Received Occupational Therapy in ... Ruth A. M. Meyers No preview available - 2006 |